Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Simian adenoviruses as vaccine vectors

Morris SJ. et al, (2016), Future Virology, 11, 649 - 659

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter

Alharbi NK. et al, (2016), Vaccine, 34, 49 - 55

Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines

Morris SJ. et al, (2016), Methods in Molecular Biology, 121 - 135

The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K

Wright J. et al, (2015), Journal of Virology, 89, 7053 - 7063

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

Cottingham MG. et al, (2012), Biotechnology and Bioengineering, 109, 719 - 728

Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange

Morris SJ. et al, (2010), BMC Biotechnology, 10

Adenovirus Late-Phase Infection Is Controlled by a Novel L4 Promoter

Morris SJ. et al, (2010), Journal of Virology, 84, 7096 - 7104

Include forthcoming?